Regarding the prognostic factors in patients with ALK-positive non-small cell lung cancer treated with crizotinib Limei Hu, Youjun Xie, Hongying Zhao

Encephalitis in non-small-cell lung cancer M. Costa e Silva, E. Silva, A. Mendes, A. Barroso

Impact of systemic inflammatory markers in patients with ALK-positive non-small cell lung cancer treated with crizotinib O.F. Olmez, A. Bilici, P. Gursoy, E. Cubukcu, A. Sakin, T. Korkmaz, I. Cil, B. Cakar, S. Menekse, T. Demir, O. Acikgoz, J. Hamdard